Bayer Leaps into CAR T-Cell Therapy Scene with Atara Biotherapeutics Collaboration

Days after Bayer announced its new cell and gene therapy strategy to maximize the capabilities of some of its recent acquisitions, the Germany-based life sciences giant is jumping into the CAR-T space and expanding its oncology focus through a collaboration with Bay Area-based Atara Biotherapeutics.